Grech D M, Spealman R D, Bergman J
Harvard Medical School, New England Regional Primate Research Center, Southborough, MA 01772, USA.
Psychopharmacology (Berl). 1996 May;125(2):97-104. doi: 10.1007/BF02249407.
Dopaminergic mechanisms are believed to play a prominent role in the self-administration of cocaine and other abused stimulants. The contribution of D2 receptors is now well established, but less is known about the role of D1 receptors in the reinforcing effects of these drugs. To help clarify the role of D1 mechanisms in stimulant self-administration, agonists differing in D1 receptor selectivity (SKF 81297 > SKF 82958 > SKF 77434) and efficacy (SKF 82958 > SKF 81297 > SKF 77434) were studied for their ability to maintain IV self-administration in squirrel monkeys previously trained to self-administer cocaine. Up to a 100-fold range of doses of each D1 agonist was studied under both a fixed-ratio (FR) and a second-order fixed-interval (FI) schedule of reinforcement. Parallel studies were conducted with the D2 receptor agonists, (+)-PHNO and quinpirole, under the second-order FI schedule. Of the three D1 agonists, only SKF 82958 maintained consistent self-administration under both the FR and second-order FI schedules and had dose-related effects that were qualitatively similar to those of (+)-PHNO and quinpirole under the latter condition. SKF 81297, which has high selectivity at D1 receptors and intermediate agonist efficacy, maintained self-administration in the majority of monkeys under the FR schedule, but did not maintain self-administration under the second-order FI schedule. SKF 77434, which has moderate selectivity at D1 receptors and low agonist efficacy, did not maintain self-administration under either schedule. The results suggest that the ability of D1 agonists to maintain IV self-administration in squirrel monkeys depends both on the type of schedule and on the pharmacological properties (i.e. selectivity and efficacy) of the particular drug. These results are also consistent with the view that D1, in addition to D2, receptor mechanisms play a role in the self-administration of abused stimulants.
多巴胺能机制被认为在可卡因及其他滥用兴奋剂的自我给药中发挥着重要作用。D2受体的作用现已明确,但D1受体在这些药物强化作用中的作用却知之甚少。为了阐明D1机制在兴奋剂自我给药中的作用,研究了D1受体选择性(SKF 81297 > SKF 82958 > SKF 77434)和效能(SKF 82958 > SKF 81297 > SKF 77434)不同的激动剂在维持松鼠猴静脉自我给药方面的能力,这些松鼠猴之前已接受过可卡因自我给药训练。在固定比率(FR)和二阶固定间隔(FI)强化程序下,研究了每种D1激动剂高达100倍剂量范围的情况。在二阶FI程序下,对D2受体激动剂(+)-PHNO和喹吡罗进行了平行研究。在三种D1激动剂中,只有SKF 82958在FR和二阶FI程序下都能维持持续的自我给药,且其剂量相关效应在性质上与后者条件下的(+)-PHNO和喹吡罗相似。SKF 81297对D1受体具有高选择性且激动剂效能中等,在FR程序下能维持大多数猴子的自我给药,但在二阶FI程序下不能维持。SKF 77434对D1受体具有中等选择性且激动剂效能低,在两种程序下均不能维持自我给药。结果表明,D1激动剂在松鼠猴中维持静脉自我给药的能力既取决于程序类型,也取决于特定药物的药理特性(即选择性和效能)。这些结果也与以下观点一致,即除了D2受体机制外,D1受体机制在滥用兴奋剂的自我给药中也发挥作用。